Spironolactone Tablet, Coated
Product Images NDC 70518-3655

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 70518-3655). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1 (Figure1)

Figure 1 (Figure1)
A Kaplan-Meier survival curve comparing the probability of an event over time in months between Spironolactone (n=822) and placebo (n=841) groups. The graph shows higher survival probability for Spironolactone. The log-rank test p-value is less than 0.001, indicating significant difference between groups.*
FDA Label Image

Figure 2 (Figure2)

Figure 2 (Figure2)
A forest plot displaying hazard ratios (HR) and 95% confidence intervals (CI) across various subgroups comparing Spironolactone 50 mg coated tablets with placebo. Subgroups include age, sex, race, LVEF percentage, heart failure type, NYHA class, diabetes status, serum creatinine, creatinine clearance, potassium levels, digoxin, ACE inhibitor, and beta blocker use. The plot shows the distribution of HR values and sample sizes for each subgroup.*
FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Spironolactone 50 mg coated tablets label showing quantity of 30 tablets. The label includes the NDC number 70518-3655-00 and indicates repackaging by RemedyRepack Inc. It mentions storage instructions and manufacturer as Oxford Pharmaceuticals, LLC.*
FDA Label Image

20 (Spironolactone Tablets Usp 1)

20 (Spironolactone Tablets Usp 1)
Chemical structure of spironolactone, a steroidal compound depicted with its characteristic rings and functional groups, including a lactone and thioacetate moiety, corresponding to the active ingredient spironolactone.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.